Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII. Treatment focuses on managing bleeding episode symptoms with clotting factor replacement therapy ...

In a 12-month study, 15 participants with severe or moderately severe hemophilia B (factor IX coagulant activity, ≤2% of the normal value) received fidanacogene elaparvovec at a dose of 5×10 11 ...

Thrombocytopenia and hemophilia are two conditions that can affect the body’s ability to form blood clots. Although they have similar symptoms, they have different causes and treatments. When a ...